When compared to control groups that received only conventional treatment, the groups treated with nano-imatinib mesylate and/or nano-hesperidin showed a notable decline in weight, tumor volume, hematological markers, cardiac markers, and downregulation of the tumor MDR-1 gene [112]. This evidence concerns the gene ABCB1 and neoplasm.